FOLH1 and prostate neoplasm: First, it demonstrates the high variability of PSMA expression in non-prostatic tumor lesions and its dependency of the local tumor microenvironment (e.g., site of metastasis, neoangiogenetic activity, organ-specific perfusion effects).